BRC news

BRC latest news

This displays the latest news items related to the Biomedical Research Centre.

Women in science: GOSH research leaders

To celebrate International Day of Women and Girls in Science, we'd like to introduce some of the fantastic research leaders at GOSH and its academic and charity partners. They all lead broad programmes to support, fund and enable child health research at GOSH and beyond. And today we're celebrating one of the things that unites them: their love of science. 

A decade of research and innovation

We are committed to providing better treatment and cures for children with complex and rare conditions around the world through research and innovation. In partnership with UCL Great Ormond Street Institute of Child Health (ICH), we form part of Europe’s largest academic centre for research and education in children’s health and disease. Join us as we look back at 10 years of innovation!

Film celebrates success of Biomedical Research Centres set up by outgoing UK Chief Medical Officer

NHS patients who have taken part in clinical trials have expressed their gratitude to researchers in a film celebrating the work of the National Institute for Health Research (NIHR) Biomedical Research Centres (BRCs), including GOSH BRC, to mark the retirement of outgoing Chief Medical Officer Professor Dame Sally Davies.

My path to research: Meet GOSH physiotherapist Lesley

Meet physiotherapist Lesley Katchburian who cares for Cora in episode four of Paul O’Grady’s Little Heroes. Lesley, who is Lead Clinical Specialist Physiotherapist for Botulinum Toxin Services in Neurodisability at GOSH, explains why botulinum toxin can be helpful for children with cerebral palsy and why research is so important. 

Novel therapy for Battens Disease available on the NHS

Patients at Great Ormond Street Hospital (GOSH) and across England are set to receive treatment for the rare nervous system condition Battens Disease, following a deal between the NHS and manufacturer Biomarin. The drug, which is called cerliponase alfa or Brineura, has been approved by the NHS following successful clinical trials at GOSH in collaboration with other centres from across the world.